Astria Therapeutics: , Including Exhibits 99.1 And 99.2, Shall Not Be Deemed Filed For Purposes Of Section 18 Of The Securities Exchange Act Of 1934, As Amended, Or Subject To The Liabilities Of That Section Or Sections 11 And 12(a)(2) Of The Securities Act Of 1933, As Amended. The Information In This Item 7.01, Including Exhibits 99.1 And 99.2, Shall Not Be Deemed Incorporated By Reference Into Any Other Filing With The U.s. Securities And Exchange Commission Made By The Company, Whether Made Before Or After The Date Hereof, Regardless Of Any General Incorporation Language In Such Filing, Other Events, Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Astria Therapeutics Inc (formerly Catabasis Pharmaceuticals Inc)
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***